Preferred Label : Hemihyperplasia, isolated;
Symbol : IH;
CISMeF acronym : HHP; IH;
Type : Phenotype or locus, molecular basis unknown;
Alternative titles and symbols : Hemihyperplasia; Hemihypertrophy, isolated; HHP;
Included titles and symbols : Hemi-3 syndrome;
Description : Isolated hemihyperplasia is an abnormality of cell proliferation leading to asymmetric
overgrowth of one or more regions of the body. The term 'hemihyperplasia' has replaced
the term 'hemihypertrophy' to describe accurately the increase in cell number found
in these patients. The incidence of isolated hemihyperplasia is estimated to be 1
in 86,000. Idiopathic hemihypertrophy is associated with increased risk of embryonal
cancers in childhood, particularly Wilms tumor (194070) (Shuman et al., 2006). Hoyme
et al. (1998) provided an anatomic classification of hemihyperplasia: complex hemihyperplasia
is involvement of half of the body, including at least 1 arm and 1 leg; affected parts
may be contralateral or ipsilateral. Simple hemihyperplasia is involvement of a single
limb. See also facial hemihyperplasia (133900). Although isolated hemihyperplasia
is a distinct clinical entity, it can also occur as a feature of overgrowth syndromes,
including Beckwith-Wiedemann syndrome (BWS; 130650), neurofibromatosis (NF1; 162200),
Proteus syndrome (176920), and Klippel-Trenaunay-Weber syndrome (149000) (Shuman et
al., 2006).;
Inheritance : Autosomal dominant;
Neoplasia : Increased risk for embryonal tumors; Increased risk for Wilms tumor;
Prefixed ID : %235000;
Origin ID : 235000;
UMLS CUI : C1856184;
Automatic exact mappings (from CISMeF team)
Currated CISMeF NLP mapping
HPO term(s)
ORDO concept(s)
Semantic type(s)
UMLS correspondences (same concept)